(Q39153165)

English

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population

scientific article published on 15 May 2014

Statements

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population (English)
15 May 2014
205-12.e1

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit